Skip to main content
Top
Published in: Medical Oncology 2/2013

Open Access 01-06-2013 | Original Paper

Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis

Authors: Adam Antczak, Monika Migdalska-Sęk, Dorota Pastuszak-Lewandoska, Karolina Czarnecka, Ewa Nawrot, Daria Domańska, Jacek Kordiak, Paweł Górski, Ewa Brzeziańska

Published in: Medical Oncology | Issue 2/2013

Login to get access

Abstract

The aim of the study was to investigate the influence of allelic imbalance (AI) in several loci of tumor suppressor genes in 3p region on the non-small cell lung cancer (NSCLC) development. We evaluated the frequency of loss of heterozygosity and/or microsatellite imbalance (LOH/MSI) and assessed their association with patients’ characteristics (age, gender, tobacco addiction) and NSCLC classification according to TNM/AJCC staging. To analyze the potential role of AI involved in NSCLC pathogenesis, we allelotyped a group of 74 NSCLC patients using 7 microsatellite markers. The highest frequency of LOH/MSI, however, not statistically significant, was observed in RARβ and MLH1 (p = 0.104 and p = 0.216, respectively) loci. The association between high LOH/MSI frequency in 3p region with male gender (p = 0.041) as well as with age (especially >60 years) for RARβ and MLH1 genes (p = 0.0001 and p = 0.020, respectively) was documented. Statistically significant increased frequency of MLH1 allelic loss in squamous cell carcinoma (SCC) versus non-squamous cell carcinoma (non-SCC) was observed (p = 0.01). Significant increase in LOH/MSI frequency in 3p region (mainly in FHIT and MLH1 loci) in correlation with cigarette addiction in a lifetime (≥40 years and ≥40 Pack Years) was also documented (p < 0.05). The highest LOH/MSI was revealed in RARβ locus in IA tumors (p = 0.0001), while the similarly high allelic loss of MLH1 correlated with III A/B tumors (p = 0.0002), according to AJCC staging. The obtained results demonstrate that AI is influenced by tobacco smoking and seems to be vital in the molecular diagnosis of NSCLC, especially of SCC subtype.
Literature
2.
go back to reference Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33.PubMedCrossRef Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33.PubMedCrossRef
3.
go back to reference Ettinger DS, Akerley W, Bepler G, et al. Non-small cell lung cancer. J Natl Compr Cancer Netw. 2010;8:740–801. Ettinger DS, Akerley W, Bepler G, et al. Non-small cell lung cancer. J Natl Compr Cancer Netw. 2010;8:740–801.
4.
go back to reference Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 2001;98:13784–9.PubMedCrossRef Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 2001;98:13784–9.PubMedCrossRef
5.
go back to reference Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450:893–8.PubMedCrossRef Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450:893–8.PubMedCrossRef
6.
go back to reference Broët P, Dalmasso C, Tan EH, et al. Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res. 2011;17:3542–50. Broët P, Dalmasso C, Tan EH, et al. Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res. 2011;17:3542–50.
7.
go back to reference Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;89:857–62.PubMedCrossRef Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;89:857–62.PubMedCrossRef
8.
go back to reference Lubin JH, Virtamo J, Weinstein SJ, Albanes D. Cigarette smoking and cancer: intensity patterns in the alpha-tocopherol, beta-carotene cancer prevention study in Finnish men. Am J Epidemiol. 2008;167:970–5. Lubin JH, Virtamo J, Weinstein SJ, Albanes D. Cigarette smoking and cancer: intensity patterns in the alpha-tocopherol, beta-carotene cancer prevention study in Finnish men. Am J Epidemiol. 2008;167:970–5.
9.
go back to reference Agudo A, Bonet C, Travier N, et al. Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. J Clin Oncol. 2012;30:4550–7. Agudo A, Bonet C, Travier N, et al. Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. J Clin Oncol. 2012;30:4550–7.
10.
go back to reference Souto-Garcia A, Fernández-Somoano A, Pascual T, Álvarez-Avellón SM, Tardón A. Association of p21 Ser31Arg and p53Arg77Pro polymorphisms with lung cancer risk in CAPUA study. Lung Cancer Targets Ther. 2012;3:69–78.CrossRef Souto-Garcia A, Fernández-Somoano A, Pascual T, Álvarez-Avellón SM, Tardón A. Association of p21 Ser31Arg and p53Arg77Pro polymorphisms with lung cancer risk in CAPUA study. Lung Cancer Targets Ther. 2012;3:69–78.CrossRef
11.
go back to reference Staaf J, Isaksson S, Karlsson A, et al. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma. Int J Cancer. 2012. doi: 10.1002/ijc.27879. Staaf J, Isaksson S, Karlsson A, et al. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma. Int J Cancer. 2012. doi: 10.​1002/​ijc.​27879.
12.
go back to reference Word B, Lyn-Cook LE Jr, Mwamba B, et al. Cigarette smoke condensate induces differential expression and promoter methylation profiles of critical genes involved in lung cancer in NL-20. Lung cells in vitro: short-term and chronic exposure. Int J Toxicol. 2012 [Epub ahead of print]. Word B, Lyn-Cook LE Jr, Mwamba B, et al. Cigarette smoke condensate induces differential expression and promoter methylation profiles of critical genes involved in lung cancer in NL-20. Lung cells in vitro: short-term and chronic exposure. Int J Toxicol. 2012 [Epub ahead of print].
13.
go back to reference Yokota J, Shiraishi K, Kohno T. Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Adv Cancer Res. 2010;109:51–72. Yokota J, Shiraishi K, Kohno T. Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Adv Cancer Res. 2010;109:51–72.
14.
go back to reference Kettunen E, Salmenkivi K, Vuopala K, et al. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer. Lung Cancer. 2006;54:169–76.PubMedCrossRef Kettunen E, Salmenkivi K, Vuopala K, et al. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer. Lung Cancer. 2006;54:169–76.PubMedCrossRef
15.
go back to reference Chmara M, Wozniak A, Ochman K, et al. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer. Anticancer Res. 2004;24:4259–63.PubMed Chmara M, Wozniak A, Ochman K, et al. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer. Anticancer Res. 2004;24:4259–63.PubMed
16.
go back to reference Tseng RC, Chang JW, Hsien FJ, et al. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer. 2005;117:241–7.PubMedCrossRef Tseng RC, Chang JW, Hsien FJ, et al. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer. 2005;117:241–7.PubMedCrossRef
17.
go back to reference Yoshino I, Fukuyama S, Kameyama T, et al. Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression. Chest. 2003;123:545–50.PubMedCrossRef Yoshino I, Fukuyama S, Kameyama T, et al. Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression. Chest. 2003;123:545–50.PubMedCrossRef
18.
go back to reference Zhou X, Kemp BL, Khuri FR, et al. Prognostic implication of microsatellite alteration profiles in early stage non-small cell lung cancer. Clin Cancer Res. 2000;6:559–65.PubMed Zhou X, Kemp BL, Khuri FR, et al. Prognostic implication of microsatellite alteration profiles in early stage non-small cell lung cancer. Clin Cancer Res. 2000;6:559–65.PubMed
19.
20.
go back to reference Girard L, Zochbauer-Muller S, Virmani AK, et al. Genomewide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000;60:4894–906.PubMed Girard L, Zochbauer-Muller S, Virmani AK, et al. Genomewide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000;60:4894–906.PubMed
21.
go back to reference Petersen S, Aninat-Meyer M, Schlüns K, et al. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer. 2000;82:65–73.PubMedCrossRef Petersen S, Aninat-Meyer M, Schlüns K, et al. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer. 2000;82:65–73.PubMedCrossRef
22.
go back to reference Edge SB, Byrd DR, Compton CC, et al. Lung. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 253–70. Edge SB, Byrd DR, Compton CC, et al. Lung. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 253–70.
24.
go back to reference Czarnecka K, Pastuszak-Lewandoska D, Migdalska-Sek M, et al. Aberrant methylation as a main mechanism of TSGs silencing in PTC. Front Biosci (Elite Ed). 2011;3:137–57.CrossRef Czarnecka K, Pastuszak-Lewandoska D, Migdalska-Sek M, et al. Aberrant methylation as a main mechanism of TSGs silencing in PTC. Front Biosci (Elite Ed). 2011;3:137–57.CrossRef
25.
go back to reference Schayek H, Krupsky M, Yaron P, et al. Genetic analyses of non-small cell lung cancer in Jewish Israeli patients. Isr Med Assoc J. 2006;8:159–63.PubMed Schayek H, Krupsky M, Yaron P, et al. Genetic analyses of non-small cell lung cancer in Jewish Israeli patients. Isr Med Assoc J. 2006;8:159–63.PubMed
26.
go back to reference Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000;25:315–9.PubMedCrossRef Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000;25:315–9.PubMedCrossRef
27.
go back to reference Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60:1949–60.PubMed Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60:1949–60.PubMed
28.
go back to reference Castagnaro A, Marangio E, Verduri A, et al. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects. Exp Lung Res. 2007;33:289–301.PubMedCrossRef Castagnaro A, Marangio E, Verduri A, et al. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects. Exp Lung Res. 2007;33:289–301.PubMedCrossRef
29.
go back to reference Zienolddiny S, Ryberg D, Arab MO, et al. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer. Br J Cancer. 2001;84:226–31.PubMedCrossRef Zienolddiny S, Ryberg D, Arab MO, et al. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer. Br J Cancer. 2001;84:226–31.PubMedCrossRef
30.
go back to reference Sozzi G, Sard L, De Gregorio L, et al. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res. 1997;57:2121–3.PubMed Sozzi G, Sard L, De Gregorio L, et al. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res. 1997;57:2121–3.PubMed
31.
go back to reference Hibi K, Takahashi T, Yamakawa K, et al. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene. 1992;7:445–9.PubMed Hibi K, Takahashi T, Yamakawa K, et al. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene. 1992;7:445–9.PubMed
32.
go back to reference Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000;60:6116–33.PubMed Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000;60:6116–33.PubMed
33.
go back to reference Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 2001;20:1509–18.PubMedCrossRef Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 2001;20:1509–18.PubMedCrossRef
34.
go back to reference Seng TJ, Currey N, Cooper WA, et al. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. Br J Cancer. 2008;99:375–82. Seng TJ, Currey N, Cooper WA, et al. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. Br J Cancer. 2008;99:375–82.
35.
go back to reference Tseng JE, Kemp BL, Khuri FR, et al. Loss of FHIT is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res. 1999;59:4798–803.PubMed Tseng JE, Kemp BL, Khuri FR, et al. Loss of FHIT is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res. 1999;59:4798–803.PubMed
36.
go back to reference Tomizawa Y, Nakajima T, Kohno T, et al. Clinicopathological significance of FHIT protein expression in stage I non-small cell lung carcinoma. Cancer Res. 1998;58:5478–83.PubMed Tomizawa Y, Nakajima T, Kohno T, et al. Clinicopathological significance of FHIT protein expression in stage I non-small cell lung carcinoma. Cancer Res. 1998;58:5478–83.PubMed
37.
go back to reference Toledo G, Sola JJ, Lozano MD, et al. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer. Mod Pathol. 2004;17:440–8.PubMedCrossRef Toledo G, Sola JJ, Lozano MD, et al. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer. Mod Pathol. 2004;17:440–8.PubMedCrossRef
38.
go back to reference Ho WL, Chang JW, Tseng RC, et al. Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer. Cancer Detect Prev. 2002;26:343–9.PubMedCrossRef Ho WL, Chang JW, Tseng RC, et al. Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer. Cancer Detect Prev. 2002;26:343–9.PubMedCrossRef
39.
go back to reference An Q, Liu Y, Gao Y, et al. Deletion of tumor suppressor genes in Chinese non-small cell lung cancer. Cancer Lett. 2002;184:189–95.PubMedCrossRef An Q, Liu Y, Gao Y, et al. Deletion of tumor suppressor genes in Chinese non-small cell lung cancer. Cancer Lett. 2002;184:189–95.PubMedCrossRef
40.
go back to reference Lee YC, Wu CT, Shih JY, et al. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. Br J Cancer. 2004;90:2378–83.PubMedCrossRef Lee YC, Wu CT, Shih JY, et al. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. Br J Cancer. 2004;90:2378–83.PubMedCrossRef
41.
go back to reference Geradts J, Fong KM, Zimmerman PV, Minna JD. Loss of FHIT expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features. Br J Cancer. 2000;82:1191–7.PubMedCrossRef Geradts J, Fong KM, Zimmerman PV, Minna JD. Loss of FHIT expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features. Br J Cancer. 2000;82:1191–7.PubMedCrossRef
42.
go back to reference Xinarianos G, Liloglou T, Prime W, et al. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res. 2000;60:4216–21.PubMed Xinarianos G, Liloglou T, Prime W, et al. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res. 2000;60:4216–21.PubMed
43.
go back to reference Wang YC, Lu YP, Tseng RC, et al. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest. 2003;111:887–95.PubMed Wang YC, Lu YP, Tseng RC, et al. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest. 2003;111:887–95.PubMed
44.
go back to reference Chang JW, Chen YC, Chen CY, et al. Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer. Clin Cancer Res. 2000;6:1639–46.PubMed Chang JW, Chen YC, Chen CY, et al. Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer. Clin Cancer Res. 2000;6:1639–46.PubMed
45.
go back to reference Geng X, Wang F, Zhang L, Zhang WM. Loss of heterozygosity combined with promoter hypermethylation, the main mechanism of human MutL Homolog (hMLH1) gene inactivation in non-small cell lung cancer in a Chinese population. Tumor. 2009;95:488–94. Geng X, Wang F, Zhang L, Zhang WM. Loss of heterozygosity combined with promoter hypermethylation, the main mechanism of human MutL Homolog (hMLH1) gene inactivation in non-small cell lung cancer in a Chinese population. Tumor. 2009;95:488–94.
46.
go back to reference Brabender J, Metzger R, Salonga D, et al. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis. 2005;26:525–30.PubMedCrossRef Brabender J, Metzger R, Salonga D, et al. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis. 2005;26:525–30.PubMedCrossRef
47.
go back to reference Martinet N, Alla F, Farré G, et al. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions. Cancer Res. 2000;60:2869–75.PubMed Martinet N, Alla F, Farré G, et al. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions. Cancer Res. 2000;60:2869–75.PubMed
48.
go back to reference Virmani AK, Rathi A, Zöchbauer-Müller S, et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst. 2000;92:1303–7.PubMedCrossRef Virmani AK, Rathi A, Zöchbauer-Müller S, et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst. 2000;92:1303–7.PubMedCrossRef
49.
go back to reference Picard E, Seguin C, Monhoven N, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst. 1999;91:1059–66.PubMedCrossRef Picard E, Seguin C, Monhoven N, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst. 1999;91:1059–66.PubMedCrossRef
50.
go back to reference Ayoub J, Jean-François R, Cormier Y, et al. Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer. J Clin Oncol. 1999;17:3546–52.PubMed Ayoub J, Jean-François R, Cormier Y, et al. Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer. J Clin Oncol. 1999;17:3546–52.PubMed
51.
go back to reference Miyakis S, Liloglou T, Kearney S, et al. Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas. Lung Cancer. 2003;39:273–7.PubMedCrossRef Miyakis S, Liloglou T, Kearney S, et al. Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas. Lung Cancer. 2003;39:273–7.PubMedCrossRef
Metadata
Title
Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis
Authors
Adam Antczak
Monika Migdalska-Sęk
Dorota Pastuszak-Lewandoska
Karolina Czarnecka
Ewa Nawrot
Daria Domańska
Jacek Kordiak
Paweł Górski
Ewa Brzeziańska
Publication date
01-06-2013
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2013
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-013-0532-9

Other articles of this Issue 2/2013

Medical Oncology 2/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.